본문으로 건너뛰기
원료CosIng 업데이트 15 10월 2010

ACETAMINOPHEN

Acetamide, N-(4-hydroxyphenyl)-

ACETAMINOPHEN은(는) EU CosIng 목록에 등재되어 있지만, 이 페이지에는 아직 직접 연결된 부속서 기록이 없습니다.

한눈에 보기

기능
Skin conditioning
CAS
103-90-2
EC
203-157-5
EU 부속서
등재되지 않음연결된 EU 부속서 기록이 없습니다. 이는 승인이 아닙니다.

시장별 규제 근거

여기에서 추적하는 시장 13곳 중 어느 곳에도 이 원료의 규칙이 가져와지지 않았습니다.

이는 이 목록에 관한 설명이지 법에 관한 설명이 아닙니다. 가져온 규칙이 없다는 것이 원료가 허용된다는 근거는 아닙니다. 규칙은 다른 명칭이나 식별자로, 또는 아직 이곳에 가져오지 않은 데이터세트에 존재할 수 있습니다.

ACETAMINOPHEN의 목록 세부 정보

INCI 명칭

ACETAMINOPHEN

INN 명칭

paracetamol

Ph. Eur. 명칭

paracetamolum

설명

Acetamide, N-(4-hydroxyphenyl)-

기록 출처

목록 참조
31569
가져온 정체
ACETAMINOPHEN
출처 업데이트
15/10/2010
유럽연합 집행위원회 CosIng 출처 주석

주요 데이터

제한 사항
—
기능

화학적 정체 및 특성

CAS 103-90-2의 PubChem 2D 화학 구조
CAS 103-90-2PubChem CID 1983

Acetaminophen

Paracetamol is a member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group. It has a role as a ferroptosis inducer, a geroprotector, a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, an antipyretic, a xenobiotic, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, a hepatotoxic agent, a cyclooxygenase 3 inhibitor, an environmental contaminant and a human blood serum metabolite. It is a member of acetamides and a member of phenols. It is functionally related to a 4-aminophenol. — ChEBI

IUPAC 명칭
N-(4-hydroxyphenyl)acetamide
분자식
C8H9NO2
분자량
151.16 g/mol
정확한 질량
151.063328530 Da
XLogP3
0.5
위상 극성 표면적
49.3 Ų
수소 결합 공여체
2
수소 결합 수용체
2
공유결합 단위
1
정의된 입체중심
0

다른 이름

Paracetamol4-AcetamidophenolTylenolAPAP4'-HydroxyacetanilideDatrilPanadolN-Acetyl-p-aminophenol
보고된 명칭 16개 더 보기
AcetaminofenAlgotropylp-Acetamidophenolp-HydroxyacetanilideDolipraneAcamolAnelixLonaridNaprinolAbensanilAcetagesicAcetalginAlvedonAnaflonApamideClixodyne
외부 데이터베이스 식별자

추가 과학 데이터베이스의 근거

EMBL-EBI ChEBI
식별자 정확히 일치CHEBI:46195

paracetamol

A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.

처방
C8H9NO2
평균 질량
151.165 g/mol
단일 동위원소 질량
151.06333 Da
형식 전하
0
  • phenols — is a (CHEBI:33853)
  • acetamides — is a (CHEBI:22160)
  • cyclooxygenase 2 inhibitor — has role (CHEBI:50629)
  • cyclooxygenase 1 inhibitor — has role (CHEBI:50630)
  • non-narcotic analgesic — has role (CHEBI:35481)
  • antipyretic — has role (CHEBI:35493)
  • non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
  • anti-HBV agent — has role (CHEBI:64951)
  • anti-HIV agent — has role (CHEBI:64946)
  • antibacterial agent — has role (CHEBI:33282)
  • xenobiotic — has role (CHEBI:35703)
  • hepatotoxic agent — has role (CHEBI:50908)
  • human blood serum metabolite — has role (CHEBI:85234)
  • cyclooxygenase 3 inhibitor — has role (CHEBI:73263)
  • environmental contaminant — has role (CHEBI:78298)
  • geroprotector — has role (CHEBI:176497)
  • ferroptosis inducer — has role (CHEBI:173085)
  • analgesic — has role (CHEBI:35480)
  • 4-aminophenol — has functional parent (CHEBI:17602)
  • cyclooxygenase 2 inhibitor — has role (CHEBI:50629)
  • cyclooxygenase 1 inhibitor — has role (CHEBI:50630)
  • non-narcotic analgesic — has role (CHEBI:35481)
  • antipyretic — has role (CHEBI:35493)
  • non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
  • anti-HBV agent — has role (CHEBI:64951)
  • anti-HIV agent — has role (CHEBI:64946)
  • antibacterial agent — has role (CHEBI:33282)
  • xenobiotic — has role (CHEBI:35703)
  • hepatotoxic agent — has role (CHEBI:50908)
  • human blood serum metabolite — has role (CHEBI:85234)
  • cyclooxygenase 3 inhibitor — has role (CHEBI:73263)
  • environmental contaminant — has role (CHEBI:78298)
  • geroprotector — has role (CHEBI:176497)
  • ferroptosis inducer — has role (CHEBI:173085)
  • analgesic — has role (CHEBI:35480)
  • anxiolytic drug — has role (CHEBI:35474)
  • anti-arrhythmia drug — has role (CHEBI:38070)
  • antirheumatic drug — has role (CHEBI:35842)
  • antineoplastic agent — has role (CHEBI:35610)
  • neuroprotective agent — has role (CHEBI:63726)
  • hypoglycemic agent — has role (CHEBI:35526)
  • antiglaucoma drug — has role (CHEBI:39456)
추가 선별 명칭
N-(4-hydroxyphenyl)acetamide4-acetamidophenol4-(Acetylamino)phenol4'-hydroxyacetanilideAcenolAcetaminofenacetaminofenacetaminophenAcetaminophenacetaminopheneAPAPEfferalganN-acetyl-p-aminophenolp-acetamidophenolp-acetaminophenolp-hydroxyacetanilidep-hydroxyphenolacetamideNSC-109028NSC-3991p-AcetylaminophenolParacetamolP-hydroxy-acetanilid
이 출처의 상호 참조
  • CAS: 103-90-2 — ChemIDplus
  • CAS: 103-90-2 — KEGG COMPOUND
  • CAS: 103-90-2 — NIST Chemistry WebBook
  • MANUAL_X_REF: 1906 — ChemSpider
  • MANUAL_X_REF: 52 — DrugCentral
  • MANUAL_X_REF: Acetaminophen — Wikipedia
  • MANUAL_X_REF: C06804 — KEGG COMPOUND
  • MANUAL_X_REF: CPD-7669 — MetaCyc
  • MANUAL_X_REF: D00217 — KEGG DRUG
  • MANUAL_X_REF: DB00316 — DrugBank
  • MANUAL_X_REF: HMDB0001859 — HMDB
  • MANUAL_X_REF: LSM-5533 — LINCS
  • MANUAL_X_REF: TYL — PDBeChem
  • REGISTRY_NUMBER: 2208089 — Beilstein
  • REGISTRY_NUMBER: 2208089 — Reaxys

매핑 기준: Exact CAS cross-reference in the ChEBI compound record. 출처 업데이트: 2026-08-29. 가져온 시각: 2026-08-31. 출처 기록 열기

NIH PubChem PUG-View
식별자 정확히 일치1983

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou 출처: CAMEO Chemicals
  • Note: This chemical does not meet GHS hazard criteria for 1.2% (5 of 432) of reports. 출처: European Chemicals Agency (ECHA)
  • Signal: Warning 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (98.1%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (17.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (17.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H412 (36.8%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 출처: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P264+P265, P270, P273, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 432 reports by companies from 47 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 5 of 432 reports by companies.; There are 45 notifications provided by 427 of 432 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H401: Toxic to aquatic life [Hazardous to the aquatic environment, acute hazard]; H411: Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 출처: NITE-CMC
  • Precautionary Statement Codes: P273, P391, and P501 (click each P-code to see the statement) 출처: NITE-CMC
  • Signal: Danger 출처: NITE-CMC
  • GHS Hazard Statements: H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H370: Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H371: May cause damage to organs [Warning Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H373: May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure] 출처: NITE-CMC
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P308+P316, P318, P319, P321, P405, and P501 (click each P-code to see the statement) 출처: NITE-CMC
  • Signal: Warning 출처: Hazardous Substances Data Bank (HSDB)
  • GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H315: Causes skin irritation [Warning Skin corrosion/irritation]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335: May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H401: Toxic to aquatic life [Hazardous to the aquatic environment, acute hazard] 출처: Hazardous Substances Data Bank (HSDB)
  • Health Effects: Skin rashes, blood disorders and a swollen pancreas have occasionally happened in people taking the drug on a regular basis for a long time. 출처: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: IDENTIFICATION AND USE: Acetaminophen is an odorless compound with a slightly bitter taste. It is a common analgesic and antipyretic agent used for the relief of fever as well as aches and pains associated with many conditions. HUMAN EXPOSURE AND TOXICITY: Nausea, vomiting, and abdominal pain usually occur within 2-3 hours after ingestion of toxic doses of the drug. In severe poisoning, CNS stimulation, excitement, and delirium may occur initially. This may be followed by CNS depression, stupor, hypothermia, marked prostration, rapid shallow breathing, rapid weak irregular pulse, low blood pressure, and circulatory failure. When an individual has ingested a toxic dose of acetaminophen, the individual should be hospitalized for several days of observation, even if there are no apparent ill effects, because maximum liver damage and/or cardiotoxic effects usually do not become apparent until 2-4 days after ingestion of the drug. Other symptoms of acute poisoning include cerebral edema and nonspecific myocardial depression. Vascular collapse results from the relative hypoxia and from a central depressant action that occurs only with massive doses. Shock may develop if vasodilation is m 출처: Hazardous Substances Data Bank (HSDB)
  • Toxicity Summary: Each year, approximately 500 fatalities and 50,000 emergency department admissions in the United States are linked to acetaminophen. In 2021, US poison control centers recorded over 80,000 cases. Acetaminophen is the most prevalent drug-related cause of acute liver failure, with hepatic injury occurring as a consequence of the drug's metabolism properties. After reaching therapeutic concentrations of oral acetaminophen, 60% to 90% of the drug undergoes metabolism in the liver, forming glucuronic acid- and sulfate-conjugate metabolites. A smaller fraction, approximately 5% to 15%, undergoes metabolism via the cytochrome P450 system (CYP450)—metabolism primarily through CYP2E1 results in the formation of the toxic intermediate NAPQI.; Under normal circumstances, NAPQI is neutralized by glutathione to form nontoxic metabolites. However, in the case of excessive doses of acetaminophen, the normal phase II drug metabolism pathways become depleted. The CYP450 pathway metabolizes a more significant portion of the acetaminophen, leading to elevated concentrations of NAPQI formation, and the limited glutathione stores can deplete. When there is a shortage of glutathione, NAPQI concentration 출처: StatPearls
  • Toxicity Summary: Paracetamol toxicity is one of the most common causes of poisoning worldwide. The toxic effects of acetaminophen are due to a minor alkylating metabolite (N-acetyl-p-benzo-quinone imine – also known as NAPQI), not acetaminophen itself nor any of the other major metabolites. Cytochromes P450 2E1 and 3A4 convert approximately 5% of paracetamol to NAPQI. This toxic metabolite reacts with sulfhydryl groups on proteins and with glutathione (GSH). NAPQI depletes the liver's natural antioxidant glutathione and directly damages cells in the liver, leading to liver failure. In animal studies, hepatic glutathione must be depleted to less than 70% of normal levels before hepatotoxicity occurs. More specifically, oxidation by NAPQI of GSH to GSSG (oxidized glutathione) and the reduction of GSSG back to GSH by the NADPH-dependent glutathione reductase appear to be responsible for the rapid oxidation of NADPH that occurs in hepatocytes incubated with NAPQI. Risk factors for toxicity include excessive chronic alcohol intake, fasting or anorexia nervosa, and the use of certain drugs such as isoniazid. At usual doses, paracetamol is quickly detoxified by combining irreversibly with the sulfhydryl g 출처: Toxin and Toxin Target Database (T3DB)
  • Environmental Bioconcentration: An estimated BCF of 3 was calculated in fish for acetaminophen(SRC), using a log Kow of 0.46(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 21(SRC), determined from a log Kow of 0.46(2) and a regression-derived equation(3), indicates that acetaminophen is expected to have very high mobility in soil(SRC). Volatilization of acetaminophen from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 8.9X10-10 atm-cu m/mole(SRC), derived from its vapor pressure, 6.29X10-5 mm Hg(4), and water solubility, 1.4X10+4 mg/L(5). Acetaminophen is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(4). The biodegradation half-lives for non-adapted, phenol-adapted, and cresol-adapted activated sludge were 21, 40, and 13 days(6), respectively, suggesting that biodegradation may be an important environmental fate process in soil given acclimation(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 21(SRC), determined from a log Kow of 0.46(2) and a regression-derived equation(3), indicates that acetaminophen is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(4) based upon an estimated Henry's Law constant of 8.9X10-10 atm-cu m/mole(SRC), derived from its vapor pressure, 6.29X10-5 mm Hg(5), and water solubility, 1.4X10+4 mg/L(6). According to a classification scheme(7), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(3), suggests the potential for bioconcentration in aquatic organisms is low(SRC). The biodegradation half-lives for non-adapted, phenol-adapted, and cresol-adapted activated sludge were 21, 40, and 13 days(8), respectively, suggesting that biodegradation may be an important environmental fate process in water given acclimation(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), acetaminophen, which has an estimated vapor pressure of 6.3X10-5 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase acetaminophen is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 22 hrs(SRC), calculated from its rate constant of 1.8X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase acetaminophen may be removed from the air by wet and dry deposition(SRC). Acetaminophen absorbs light at wavelengths >290 nm(4) and, therefore, may be susceptible to direct photolysis by sunlight(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Sources/Uses: Registered for use in the US for control of brown tree snakes; [NPIRS] Used to make azo dyes, photographic chemicals, and pharmaceuticals, as a stabilizer for hydrogen peroxide, and as a therapeutic analgesic and antipyretic; [HSDB] 출처: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: Manufacture of azo dyes, photographic chemicals. 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: Stabilizer for hydrogen peroxide 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: An analgesic used as an aspirin substitute 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: Analgesics, Non-Narcotic; Antipyretics 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: For more Uses (Complete) data for ACETAMINOPHEN (6 total), please visit the HSDB record page. 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: Use (kg) in Switzerland (2009): >100000; Use (kg; approx.) in Germany (2009): >500000; Use (kg; exact) in Germany (2009): 564712; Use (kg) in USA (2002): 5790000; Use (kg) in France (2004): 3303077; Consumption (g per capita) in Switzerland (2009): 13; Consumption (g per capita; approx.) in Germany (2009): 6.1; Consumption (g per capita; exact) in Germany (2009): 6.9; Consumption (g per capita) in the USA (2002): 21; Consumption (g per capita) in France (2004): 55; Excretion rate: 0.037; Calculated removal (%): 75.1 출처: NORMAN Suspect List Exchange
  • Uses: An over-the-counter analgesic (pain reliever) and antipyretic (fever reducer). It is commonly used for the relief of fever, headaches, and other minor aches and pains, and is a major ingredient in numerous cold and flu remedies. 출처: Toxin and Toxin Target Database (T3DB)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
EMBL-EBI ChEBI정확히 일치2026-08-31
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

공식 EU 원료 명칭 근거

이 원료 명칭은 공식 2025 EU 일반 원료 명칭 용어집과 정확히 일치합니다.

처방 기능이 겹치는 원료

추가 공식 및 과학 출처

이 정체를 확인할 외부 데이터베이스 11개

CosIng 목록에서 ACETAMINOPHEN이(가) 나타나는 방식

CosIng 목록은 ACETAMINOPHEN을(를) 화장품 원료로 나열하며, 이 페이지는 이를 부속서 기록 0건과 연결합니다. 목록 항목은 명칭과 식별자를 담고 있으며, 부속서 기록은 해당 물질이 EU 화장품 법령에서 사용금지, 사용제한 또는 허용 목록(포지티브 리스트)에 있는 위치를 보여 줍니다.

ACETAMINOPHEN은(는) 공식 데이터에서 화장품 기능 1개로도 태그되어 있습니다. 기능 표시는 의도된 용도를 설명하지만, 처방 또는 표시 작업 전에 연결된 부속서 기록에 대한 규제 검토를 대체하지 않습니다.

자주 묻는 질문

ACETAMINOPHEN은(는) 현재 직접 연결된 부속서 제한 기록 없이 EU CosIng 원료 목록에 등재되어 있습니다. 부속서 링크가 없다고 해서 제한 없는 사용이 보장되는 것은 아니므로, 처방하기 전에 항상 현행 공식 CosIng 데이터베이스로 확인하세요.

EU CosIng 목록에 따르면 ACETAMINOPHEN에는 다음 기능이 지정되어 있습니다:

CAS 103-90-2은(는) 여러 EU 부속서 기록에 나타날 수 있습니다. CAS 조회 페이지에서는 이 식별자를 공유하는 모든 부속서 II–VI 항목을 보여 주며, 동일한 화학 물질의 부속서 간 규제 상태를 파악하는 데 유용합니다.

INCI 검사기를 사용하여 선택한 시장 전반에서 전체 원료 목록을 선별하거나, 지원되는 모든 시장 데이터세트에서 이 물질을 비교하세요.

ACETAMINOPHEN의 출처 주석

이 페이지는 공개된 유럽연합 집행위원회 화장품 원료 자료에서 가져온 ACETAMINOPHEN의 CosIng 목록 항목을 재현하며, 현재 직접 연결된 부속서 일치 항목이 없는 경우에도 연결된 식별자를 표시합니다.

이 목록 페이지를 이용해 ACETAMINOPHEN을(를) 조사하고 연결된 기록을 비교하되, 규제 판단을 내리기 전에 제한 사항과 법적 상태를 현행 공식 출처 본문 및 법령으로 확인하세요.

도구 및 다음 단계

처방 확인

전체 INCI 목록을 검사하여 ACETAMINOPHEN 및 연결된 EU 부속서 제한 사항이나 알레르겐 표시를 찾으세요.

INCI 검사기

유사 원료 검색

ACETAMINOPHEN, 그 식별자 또는 인접한 명칭 변형과 관련된 다른 목록 원료와 부속서 항목을 찾으세요.

검색